Ardea Biosciences, Inc
USPTO PatentsView assignee record - 16 granted patents across 7 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Ardea ranks #17,451 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 7 technology areas.
- #17,451
- of 49,997 US assignees by volume
- 21st percentile
- by Innovation Score (26.8/100)
- 12.8
- avg claims per patent
- -77%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17451 · US Corporation #17,451 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 16 grants
- MID-PACK #17,451/49,997
- PHOTO-FINISH Angion Biomedica
- CPC-NARROW A61P · 7 areas
- INNOV-THIN 26.8/100
- CLAIMS-RICH 12.8 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -77% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Angion Biomedica Corp. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ardea’s 26.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ardea
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ardea Biosciences · this assignee 27
Ardea Biosciences · this assignee
27 score
- Autel NEW Energy · near 27
Autel NEW Energy · near
27 score
- BugMD · near 27
BugMD · near
27 score
- Dongguan DaXianGuang… · near 27
Dongguan DaXianGuang… · near
27 score
- Xebec Technology · near 27
Xebec Technology · near
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ardea's Innovation Score is 26.8/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ardea?
Each dot is one of Ardea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ardea’s own 12.8 claims/patent is at or below the 13.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Ardea's grants concentrate
Ardea Biosciences, Inc is a focused PatentsView assignee: 7 CPC subclasses with 93.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2021. By volume, Ardea sits between Angion Biomedica Corp. and AspenTech Corporation.
Who files at Ardea's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Angion Biomedica
Angion Biomedica Corp.
16 patents
- Apicore US
Apicore US LLC
16 patents
- Aqua-aerobic Syst…
Aqua-Aerobic Systems, Inc.
16 patents
- Aquabeam
AquaBeam, LLC
16 patents
- Arriver Software…
Arriver Software AB
16 patents
- Arrowhead Research
Arrowhead Research Corporation
16 patents
- Asensus Surgical…
Asensus Surgical Europe S.a.r.l.
16 patents
- Aspentech
AspenTech Corporation
16 patents
- Ardea Biosciences ◀
Ardea Biosciences, Inc
16 patents
What this shows Ardea holds 16 patents at rank #17,460, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ardea
By rank, the assignees closest to #17,460 in granted patent volume.
- Angion Biomedica Corp. #17,456 · 16 patents
- Apicore US LLC #17,457 · 16 patents
- Aqua-Aerobic Systems, Inc. #17,458 · 16 patents
- AquaBeam, LLC #17,459 · 16 patents
- Arriver Software AB #17,461 · 16 patents
- Arrowhead Research Corporation #17,462 · 16 patents
- Asensus Surgical Europe S.a.r.l. #17,463 · 16 patents
- AspenTech Corporation #17,464 · 16 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Ardea's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Ardea, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Ardea ranks #1,291 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (27 here).
Ardea's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 21st percentile higher than 21% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 37.5% |
| 2016 | 3 | 18.8% |
| 2018 | 2 | 12.5% |
| 2019 | 2 | 12.5% |
| 2020 | 2 | 12.5% |
| 2021 | 1 | 6.3% |
Which technologies does Ardea Biosciences, Inc patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ardea Biosciences, Inc's patent record in context - here's where to go next.
- Ardea Biosciences, Inc's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 93.8% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #17,451 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ardea Biosciences, Inc against Angion Biomedica Corp., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.